Published in Zh Mikrobiol Epidemiol Immunobiol on March 07, 2011
Hemolysin plasmid coding for the virulence of a nephropathogenic Escherichia coli strain. Infect Immun (1982) 2.00
Haemolysis by urinary Escherichia coli and virulence in mice. J Med Microbiol (1981) 1.50
Virulence of urinary and faecal Escherichia coli in relation to serotype, haemolysis and haemagglutination. J Hyg (Lond) (1982) 1.50
Sequence variation in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes. Virus Res (2004) 1.35
Virulence of Escherichia coli in experimental hematogenous pyelonephritis in mice. Infect Immun (1979) 1.35
Monoclonal antibodies that recognize the P fimbriae F71, F72, F9, and F11 from uropathogenic Escherichia coli. Infect Immun (1985) 1.27
Detection of the beta2 toxin gene of Clostridium perfringens in diarrhoeic piglets in The Netherlands and Switzerland. FEMS Immunol Med Microbiol (1999) 1.20
Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential. Vaccine (2006) 1.16
Surface antigens from Escherichia coli O2 and O78 strains of avian origin. Infect Immun (1990) 1.14
RTX toxin genotypes and phenotypes in Actinobacillus pleuropneumoniae field strains. J Clin Microbiol (1994) 1.09
Monoclonal antibodies raised against Pap fimbriae recognize minor component(s) involved in receptor binding. Microb Pathog (1987) 1.05
Genetic stability of cold-adapted A/Leningrad/134/47/57 (H2N2) influenza virus: sequence analysis of live cold-adapted reassortant vaccine strains before and after replication in children. J Gen Virol (1995) 1.04
Memory T-cell immune response in healthy young adults vaccinated with live attenuated influenza A (H5N2) vaccine. Clin Vaccine Immunol (2011) 0.99
Serological response to the P fimbriae of uropathogenic Escherichia coli in pyelonephritis. Infect Immun (1987) 0.98
A single immunization with CoVaccine HT-adjuvanted H5N1 influenza virus vaccine induces protective cellular and humoral immune responses in ferrets. J Virol (2010) 0.96
Evaluation of an indirect enzyme-linked immunosorbent assay (ELISA) for detection of antibodies to the Apx toxins of Actinobacillus pleuropneumoniae. Vet Microbiol (2000) 0.95
Virulence of Escherichia coli strains isolated from urine of patients with acute cystitis and from faeces of healthy women. Antonie Van Leeuwenhoek (1981) 0.93
Monoclonal antibodies for serotyping the P fimbriae of uropathogenic Escherichia coli. J Clin Microbiol (1986) 0.92
Review of companion animal viral diseases and immunoprophylaxis. Vaccine (2008) 0.90
Efficacy of a pandemic (H1N1) 2009 virus vaccine in pigs against the pandemic influenza virus is superior to commercially available swine influenza vaccines. Vet Microbiol (2011) 0.88
[Monoclonal immunoenzyme test-system for evaluating secretory immunity to influenza A and B viruses]. Vopr Virusol (1998) 0.85
K antigens of Escherichia coli and virulence in urinary-tract infection: studies in a mouse model. J Med Microbiol (1983) 0.85
[Genome composition analysis of the reassortant influenza viruses used in seasonal and pandemic live attenuated influenza vaccine]. Mol Gen Mikrobiol Virusol (2011) 0.84
Important mammalian veterinary viral immunodiseases and their control. Vaccine (2012) 0.84
Development of an efficient PCR method for toxin typing of Actinobacillus pleuropneumoniae strains. Mol Cell Probes (1995) 0.84
Human airway epithelial cells present antigen to influenza virus-specific CD8+ CTL inefficiently after incubation with viral protein together with ISCOMATRIX. Vaccine (2004) 0.84
[Effect of the times of remantadine administration on its content in MDCK cells and white mouse lung tissues infected and uninfected with the influenza virus]. Vopr Virusol (1982) 0.82
Virulence of Escherichia coli in acute pyelonephritis, acute cystitis and asymptomatic bacteriuria. Antonie Van Leeuwenhoek (1980) 0.81
[A comparative study of live and inactivated influenza vaccines: the organization of the observation and the results of a study of their reactogenicity and immunogenicity]. Vopr Virusol (1994) 0.81
RNase-sensitive and RNase-insensitive protective components isolated from Listeria monocytogenes. Antonie Van Leeuwenhoek (1985) 0.81
Feasibility of single-shot H5N1 influenza vaccine in ferrets, macaques and rabbits. Vaccine (2010) 0.81
T-cell-independent macrophage activation in mice induced with rRNA from Listeria monocytogenes and dimethyldioctadecylammonium bromide. Infect Immun (1986) 0.80
[Restriction analysis of genome composition of live influenza vaccine]. Vopr Virusol (2011) 0.80
[Humoral and cell-mediated immune responses in humans to the A/California/07/ 2009 (H1N1) virus, A(H1N1)pdm2009]. Vopr Virusol (2013) 0.79
Ribonuclease-sensitive ribosomal vaccines. Antonie Van Leeuwenhoek (1984) 0.78
[PCR restriction analysis of the genome composition of reassortant cold-adapted influenza B virus strains]. Vopr Virusol (2007) 0.78
[Study of biological properties of cold-adapted reassortant strain of influenza virus subtype H7N3]. Zh Mikrobiol Epidemiol Immunobiol (2009) 0.78
[Efficacy of production of reassortant of epidemic strains and cold-adapted influenza viruses in chicken embryo and MDCK cells]. Zh Mikrobiol Epidemiol Immunobiol (2008) 0.78
[Phenotyte of epidemic influenza B virus strains isolated in different years]. Vopr Virusol (2006) 0.78
[Effect of Point Mutations in the Polymerase Genes of the Influenza A/PR/8/34 (H1N1) Virus on the Immune Response in a Mouse Model]. Vopr Virusol (2015) 0.77
Associated seroconversions to respiratory viruses in volunteers with experimental influenza infection. Acta Virol (1976) 0.77
[Stimulation of homo- and heterologic T-cell immunological memory in volunteers inoculated with live influenza A (H5N2) reassortant vaccine]. Vopr Virusol (2012) 0.77
[The comparative characteristics of the safety, immunogenic activity and prophylactic potency of the adult and children types of live influenza vaccine in schoolchildren aged 7-14 years]. Vopr Virusol (2002) 0.77
Comparison of live attenuated and inactivated influenza vaccines in schoolchildren in Russia: I. Safety and efficacy in two Moscow schools, 1987/88. Vaccine (1993) 0.77
[A comparative study of the inoculation properties of live recombinant and inactivated influenza vaccines made from strain A/Philippines/2/82 (H3N2) in 8- to 15-year-old children]. Vopr Virusol (1992) 0.77
Immunoprophylaxis against important virus disease of horses, farm animals and birds. Vaccine (2009) 0.77
[The inoculation properties of live recombinant influenza vaccine types A and B used separately and jointly in children 3 to 14]. Vopr Virusol (1992) 0.76
T lymphocytes as an indicator in influenza vaccination, influenza and acute respiratory diseases. Acta Virol (1978) 0.76
[Prophylactic effectiveness of a live recombinant influenza type A vaccine in immunizing children aged 3-14 years]. Vopr Virusol (1996) 0.76
Nucleotide sequences of the neuraminidase genes of influenza A/Leningrad/134/57 (H2N2) virus and two of its live, attenuated, cold-adapted variants. Virus Genes (1995) 0.75
[Contribution of neuraminidase of influenza viruses to the sensitivity to the serum inhibitors and reassortment efficiency]. Mol Gen Mikrobiol Virusol (2014) 0.75
[Genetic and phenotypic analysis of heterogeneous population of a cold-adapted donor of the A/Leningrad/134/17/57 (H2N2) attenuation and of the donor-based reassortant influenza vaccine strains]. Vopr Virusol (2005) 0.75
Dissociation between enhanced resistance and delayed hypersensitivity induced with subcellular preparations from Listeria monocytogenes and the adjuvant dimethyl-dioctadecyl-ammonium bromide. Antonie Van Leeuwenhoek (1986) 0.75
[Genetic stability of cold-adapted influenza viruses]. Vopr Virusol (2006) 0.75
Generation of influenza transfectants using purified recombinant nucleocapsid protein. J Virol Methods (1998) 0.75
Development and qualification of the parallel line model for the estimation of human influenza haemagglutinin content using the single radial immunodiffusion assay. Vaccine (2011) 0.75
[The investigation of the safety, genetic stability and immunogenicity of live influenza vaccine for adults in vaccination of 3-6 years old children]. Vopr Virusol (2002) 0.75
[Heart rate variability before and after coronary artery bypass surgery in patients with ischemic heart disease]. Kardiologiia (2002) 0.75
[Antitumor activity of cold-adapted strains of influenza virus in a model transformed murine tumor cells]. Vopr Virusol (1999) 0.75
[Effect of non-specific inhibitors in horse serum on human adenoviruses]. Vopr Virusol (1972) 0.75
[Reactogenic properties and the immunological activity of an absorbed influenza chemical vaccine]. Tr Inst Im Pastera (1976) 0.75
[Peculiarity of reassortment of current wild type influenza viruses with master donor viruses for live influenza vaccine]. Vopr Virusol (2014) 0.75
[The temperature sensitivity of epidemic influenza A viruses as a marker of immunogenicity of reassortant vaccinal strains]. Vopr Virusol (2003) 0.75
[Immune response to live influenza vaccine]. Vestn Ross Akad Med Nauk (2002) 0.75
[Criteria of primary screening of attenuated strains for live vaccine against Influenza A]. Vopr Virusol (2001) 0.75
[The biological properties of 2 strains of adenovirus serotype 4]. Vopr Virusol (1972) 0.75
[Endogenous erythropoietin, acute kidney injury, and prognosis in patients with acute coronary syndrome]. Ter Arkh (2015) 0.75
Interferon and other proinflamatory cytokine responses in vitro following infection with wild-type and cold-adapted reassortant influenza viruses. Vaccine (2006) 0.75
[Effect of remantadine on the development of toxicoses caused by different strains of influenza virus]. Vopr Virusol (1982) 0.75
[Study of the biology of intratype variants of adenovirus serotypes 1, 2, 3, 4 and 7]. Vestn Akad Med Nauk SSSR (1970) 0.75
[Experience with using autologous transfusion of ultraviolet- irradiated blood]. Ortop Travmatol Protez (1989) 0.75
Transfer of enhanced resistance against Listeria monocytogenes induced with ribosomal RNA and the adjuvant dimethyldioctadecylammonium bromide. Immunol Lett (1986) 0.75
[Growth characteristics of single gene mutants of A/Leningrad/134/57(H2N2) influenza virus and cold-adapted mutant A/Leningrad/134/17/57(H2N2)]. Vopr Virusol (2007) 0.75
[Codon optimization of hemagglutinin as a promising tool for improving of the influenza vaccines immunogenicity]. Mol Gen Mikrobiol Virusol (2014) 0.75
[Dynamics of heart rate variability in ischemic heart disease patients after coronary artery bypass grafting]. Kardiologiia (2003) 0.75
[Live influenza vaccine: laboratory markers of attenuation]. Vopr Virusol (2007) 0.75
[Analysis of mutations in the genome of cold-adapted strains of influenza A virus using extended modification of polymerase chain restriction method]. Vopr Virusol (2003) 0.75
[Dynamics of adenovirus reproduction in the liver of newborn hamsters and changes in humoral immunity factors in experimental adenovirus hepatitis]. Vopr Virusol (1972) 0.75
[Effect of remantadine on the immunodepressive action of influenza virus]. Vopr Virusol (1982) 0.75
Urinary virulence of E. coli in experimental haematogenous pyelonephritis. Antonie Van Leeuwenhoek (1979) 0.75
Contamination mechanisms of air basin with tritium in venues of underground nuclear explosions at the former Semipalatinsk test site. J Environ Radioact (2012) 0.75